May 1 2018
Is Gilead’s 2018 Hepatitis C drug Franchise Outlook in Trouble?
Mizuho | Investor's Business Daily
May 1 2018
Why Cities Like Dayton and Sarastoa Are Feeling GrubHub’s Growth
Mizuho | Chicago Tribune
Apr 30 2018
Celgene Topples on Report its MS Drug Could be Delayed by 3 Years
Mizuho | Investor's Business Daily
Apr 30 2018
Is Welltower’s Deal with ProMedica a Risky Venture or a Smart Move?
Mizuho | National Real Estate Investor
Apr 30 2018
Allergan Tops First-Quarter Views, But Dips on Report Its ‘Unlikely’ to Make a Deal
Mizuho | Investor's Business Daily